(not new, but nice anyway...)
Forefront, Mayo Clinic, Volume 4, issue 4, 2015
Researchers in the Mayo Clinic Cancer Center are studying a novel drug called imetelstat for the treatment of patients with myelofibrosis. Results of a Mayo Clinic study of the drug were published in the New England Journal of Medicine in September 2015.
"We observed that imetelstat was active and induced morphologic and molecular remissions in some patients with myelofibrosis," said Ayalew Tefferi, M.D., a hematologist in the Mayo Clinic Cancer Center and lead author of the published study. "We also observed that imetelstat demonstrated selective anticlonal activity, inhibiting the growth of cancer cells, which we had not previously documented with other drugs."
full article: http://www.mayo.edu/research/forefront/ ... s-patients
Mayo Clinic Forefront: Novel drug may benefit myelofibrosis patients
Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
-
- Site Admin
- Posts: 531
- Joined: Thu Dec 03, 2015 3:39 pm